Breunig K, Lei X, Montalbano M, Guardia G, Ostadrahimi S, Alers V
Elife. 2025; 13.
PMID: 39937575
PMC: 11820137.
DOI: 10.7554/eLife.98152.
Li F, Karimi N, Wang S, Pan T, Dong J, Wang X
Cell Prolif. 2024; 57(7):e13655.
PMID: 38764347
PMC: 11216927.
DOI: 10.1111/cpr.13655.
Ciocia A, Mestre-Farras N, Vicent-Nacht I, Guitart T, Gebauer F
NAR Cancer. 2024; 6(2):zcae014.
PMID: 38600987
PMC: 11005786.
DOI: 10.1093/narcan/zcae014.
Rouse W, Tompkins V, OLeary C, Moss W
Nucleic Acids Res. 2024; 52(11):6596-6613.
PMID: 38554103
PMC: 11194067.
DOI: 10.1093/nar/gkae220.
Indacochea A, Guitart T, Boada A, Peg V, Quer A, Laayouni H
Int J Mol Sci. 2024; 25(4).
PMID: 38396995
PMC: 10889260.
DOI: 10.3390/ijms25042319.
Alternative splicing and related RNA binding proteins in human health and disease.
Tao Y, Zhang Q, Wang H, Yang X, Mu H
Signal Transduct Target Ther. 2024; 9(1):26.
PMID: 38302461
PMC: 10835012.
DOI: 10.1038/s41392-024-01734-2.
The RNA-binding protein CSDE1 promotes hematopoietic stem and progenitor cell generation via translational control of Wnt signaling.
Li Y, Li C, Liu M, Liu S, Liu F, Wang L
Development. 2023; 150(21).
PMID: 37874038
PMC: 10652045.
DOI: 10.1242/dev.201890.
TDP-43 protein interactome informs about perturbed canonical pathways and may help develop personalized medicine approaches for patients with TDP-43 pathology.
Helmold B, Pauss K, Ozdinler P
Drug Discov Today. 2023; 28(11):103769.
PMID: 37714405
PMC: 10872580.
DOI: 10.1016/j.drudis.2023.103769.
Trap and ambush therapy using sequential primary and tumor escape-selective oncolytic viruses.
Webb M, Kottke T, Kendall B, Swanson J, Uzendu C, Tonne J
Mol Ther Oncolytics. 2023; 29:129-142.
PMID: 37313455
PMC: 10258242.
DOI: 10.1016/j.omto.2023.05.006.
Targeting an essential cold shock protein to block growth and transmission of malaria parasite.
Behl A, Shoaib R, De Leon F, Kumari G, Saini M, Madan E
iScience. 2023; 26(5):106637.
PMID: 37192974
PMC: 10182332.
DOI: 10.1016/j.isci.2023.106637.
Eosinophilic esophagitis-associated epithelial remodeling may limit esophageal carcinogenesis.
Fuller A, Karami A, Kabir M, Klochkova A, Jackson J, Mu A
Front Allergy. 2023; 4:1086032.
PMID: 37064719
PMC: 10090679.
DOI: 10.3389/falgy.2023.1086032.
Upstream of N-Ras C-terminal cold shock domains mediate poly(A) specificity in a novel RNA recognition mode and bind poly(A) binding protein.
Hollmann N, Jagtap P, Linse J, Ullmann P, Payr M, Murciano B
Nucleic Acids Res. 2023; 51(4):1895-1913.
PMID: 36688322
PMC: 9976900.
DOI: 10.1093/nar/gkac1277.
Elusive Trans-Acting Factors Which Operate with Type I (Poliovirus-like) IRES Elements.
Andreev D, Niepmann M, Shatsky I
Int J Mol Sci. 2022; 23(24).
PMID: 36555135
PMC: 9778869.
DOI: 10.3390/ijms232415497.
Probing the dynamic RNA structurome and its functions.
Spitale R, Incarnato D
Nat Rev Genet. 2022; 24(3):178-196.
PMID: 36348050
PMC: 9644009.
DOI: 10.1038/s41576-022-00546-w.
Cold shock domain-containing protein E1 is a posttranscriptional regulator of the LDL receptor.
Smith G, Padmanabhan A, Lau B, Pampana A, Li L, Lee C
Sci Transl Med. 2022; 14(662):eabj8670.
PMID: 36103516
PMC: 10174261.
DOI: 10.1126/scitranslmed.abj8670.
Novel Driver Strength Index highlights important cancer genes in TCGA PanCanAtlas patients.
Belikov A, Vyatkin A, Leonov S
PeerJ. 2022; 10:e13860.
PMID: 35975235
PMC: 9375969.
DOI: 10.7717/peerj.13860.
LINC01234 Accelerates the Progression of Breast Cancer via the miR-525-5p/Cold Shock Domain-Containing E1 Axis.
Yu J, Zhang X, He R, Yang X, Hu J, Tan F
Dis Markers. 2022; 2022:6899777.
PMID: 35923244
PMC: 9343190.
DOI: 10.1155/2022/6899777.
Management of Pheochromocytomas and Paragangliomas: A Case-Based Review of Clinical Aspects and Perspectives.
Sobocki B, Perdyan A, Szot O, Rutkowski J
J Clin Med. 2022; 11(9).
PMID: 35566714
PMC: 9103340.
DOI: 10.3390/jcm11092591.
Reduced miR-371b-5p expression drives tumor progression via CSDE1/RAC1 regulation in triple-negative breast cancer.
Kim Y, Ko J, Lee S, Oh S, Park J, Kang H
Oncogene. 2022; 41(22):3151-3161.
PMID: 35490208
PMC: 9135623.
DOI: 10.1038/s41388-022-02326-6.
AGO-RBP crosstalk on target mRNAs: Implications in miRNA-guided gene silencing and cancer.
Kakumani P
Transl Oncol. 2022; 21:101434.
PMID: 35477066
PMC: 9136600.
DOI: 10.1016/j.tranon.2022.101434.